Who Paid My Doc Search
Menu
Organisation paid for research Program year 2021 Source: CMS Open Payments

Vance Thompson Vision Sioux Falls

Neither a doctor nor a teaching hospital

Research payments

$181,662

13 payments

Through program year 2021, Vance Thompson Vision Sioux Falls is reported as receiving $181,662 in research payments, across 13 payments.

By program year

1 row
Year Kind Amount Payments
2021 Research $181,662 13

Breakdown

Who paid Research payments · program year 2021
  1. Novartis Pharmaceuticals Corporation $124,690 2 payments
  2. Carl Zeiss Meditec, Inc. $56,973 11 payments
Studies the money was for Research payments · program year 2021
  1. A Randomized, Placebo-Controlled, Double-Masked, Multi-Center, Dose-Ranging Study to Evaluate the Safety, and Efficacy of Unr844 in Subjects With Presbyopia $72,141 1 payment
  2. A Randomized, Double-Masked, Multicenter Study to Evaluate the Safety and Efficacy of Ecf843 VS Vehicle in Subjects With Dry Eye Disease $52,549 1 payment
  3. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $11,608 1 payment
  4. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $10,364 1 payment
  5. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $8,966 1 payment
  6. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $8,124 1 payment
  7. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $6,297 1 payment
  8. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $3,260 1 payment
  9. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $3,054 1 payment
  10. A Prospective Multicenter Clinical Study To Evaluate The Safety And Effectiveness of the MEL 90 Excimer Laser Using LASIK (Laser in Situ Keratomileusis) for the Correction of Myopia, Hyperopia, Astigmatism and Mixed Astigmatism. $2,240 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record